154 related articles for article (PubMed ID: 2852792)
1. Reactogenicity and antigenicity of rhesus rotavirus vaccine (MMU-18006) in newborn infants in Venezuela.
Flores J; Daoud G; Daoud N; Puig M; Martinez M; Perez-Schael I; Shaw R; Greenberg HB; Midthun K; Kapikian AZ
Pediatr Infect Dis J; 1988 Nov; 7(11):776-80. PubMed ID: 2852792
[TBL] [Abstract][Full Text] [Related]
2. Vaccination of Thai infants with rhesus-human reassortant tetravalent oral rotavirus vaccine.
Simasathien S; Migasena S; Samakoses R; Pitisuttitham P; Sangaroon P; Aree C; Bishop R; Bugg H; Davidson BL; Vesikari T
Pediatr Infect Dis J; 1994 Jul; 13(7):590-6. PubMed ID: 7970945
[TBL] [Abstract][Full Text] [Related]
3. Reactogenicity and immunogenicity of a high-titer rhesus rotavirus-based quadrivalent rotavirus vaccine.
Flores J; Perez-Schael I; Blanco M; Rojas AM; Alfonzo E; Crespo I; Cunto W; Pittman AL; Kapikian AZ
J Clin Microbiol; 1993 Sep; 31(9):2439-45. PubMed ID: 8408569
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of diarrheal diseases in Venezuelan children to evaluate the efficacy of rhesus rotavirus vaccine.
Perez-Schael I; Garcia D; Gonzalez M; Gonzalez R; Daoud N; Perez M; Cunto W; Kapikian AZ; Flores J
J Med Virol; 1990 Mar; 30(3):219-29. PubMed ID: 2160516
[TBL] [Abstract][Full Text] [Related]
5. Reactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants.
Flores J; Perez-Schael I; Blanco M; Vilar M; Garcia D; Perez M; Daoud N; Midthun K; Kapikian AZ
J Clin Microbiol; 1989 Mar; 27(3):512-8. PubMed ID: 2541168
[TBL] [Abstract][Full Text] [Related]
6. Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants.
Flores J; Perez-Schael I; Gonzalez M; Garcia D; Perez M; Daoud N; Cunto W; Chanock RM; Kapikian AZ
Lancet; 1987 Apr; 1(8538):882-4. PubMed ID: 2882289
[TBL] [Abstract][Full Text] [Related]
7. An efficacy trial of the rhesus rotavirus vaccine in Maryland. The Clinical Study Group.
Rennels MB; Losonsky GA; Young AE; Shindledecker CL; Kapikian AZ; Levine MM
Am J Dis Child; 1990 May; 144(5):601-4. PubMed ID: 2330930
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group.
Bernstein DI; Glass RI; Rodgers G; Davidson BL; Sack DA
JAMA; 1995 Apr; 273(15):1191-6. PubMed ID: 7707626
[TBL] [Abstract][Full Text] [Related]
9. Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants.
Perez-Schael I; Blanco M; Vilar M; Garcia D; White L; Gonzalez R; Kapikian AZ; Flores J
J Clin Microbiol; 1990 Mar; 28(3):553-8. PubMed ID: 2157737
[TBL] [Abstract][Full Text] [Related]
10. Horizontal transmission of rhesus monkey rotavirus-based quadrivalent vaccine during a phase 3 clinical trial in Caracas, Venezuela.
Hoshino Y; Wagner M; Yan XY; Perez-Schael I; Kapikian AZ
J Infect Dis; 2003 Mar; 187(5):791-800. PubMed ID: 12599053
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela.
Pérez-Schael I; Guntiñas MJ; Pérez M; Pagone V; Rojas AM; González R; Cunto W; Hoshino Y; Kapikian AZ
N Engl J Med; 1997 Oct; 337(17):1181-7. PubMed ID: 9337376
[TBL] [Abstract][Full Text] [Related]
12. Rotavirus specific breast milk antibody in two populations and possible correlates of protection.
Losonsky GA; D'Alessandra de Rimer H
Adv Exp Med Biol; 1991; 310():265-9. PubMed ID: 1667067
[TBL] [Abstract][Full Text] [Related]
13. Effect of dose and a comparison of measures of vaccine take for oral rhesus rotavirus vaccine. The Maryland Clinical Studies Group.
Pichichero ME; Losonsky GA; Rennels MB; Disney FA; Green JL; Francis AB; Marsocci SM
Pediatr Infect Dis J; 1990 May; 9(5):339-44. PubMed ID: 2162027
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and reactogenicity of lowered doses of rhesus rotavirus vaccine strain MMU 18006 in young children.
Rennels MB; Losonsky GA; Shindledecker CL; Hughes TP; Kapikian AZ; Levine MM
Pediatr Infect Dis J; 1987 Mar; 6(3):260-4. PubMed ID: 3033593
[TBL] [Abstract][Full Text] [Related]
15. Comparison of reactogenicity and antigenicity of M37 rotavirus vaccine and rhesus-rotavirus-based quadrivalent vaccine.
Flores J; Perez-Schael I; Blanco M; White L; Garcia D; Vilar M; Cunto W; Gonzalez R; Urbina C; Boher J
Lancet; 1990 Aug; 336(8711):330-4. PubMed ID: 1975333
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: A randomized, placebo-controlled trial in Latin American infants.
Salinas B; Pérez Schael I; Linhares AC; Ruiz Palacios GM; Guerrero ML; Yarzábal JP; Cervantes Y; Costa Clemens S; Damaso S; Hardt K; De Vos B
Pediatr Infect Dis J; 2005 Sep; 24(9):807-16. PubMed ID: 16148848
[TBL] [Abstract][Full Text] [Related]
17. Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccinees: implications for vaccine development.
Green KY; Taniguchi K; Mackow ER; Kapikian AZ
J Infect Dis; 1990 Apr; 161(4):667-79. PubMed ID: 2156942
[TBL] [Abstract][Full Text] [Related]
18. Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European Infants: a randomized phase IIIb study.
Omenaca F; Sarlangue J; Szenborn L; Nogueira M; Suryakiran PV; Smolenov IV; Han HH;
Pediatr Infect Dis J; 2012 May; 31(5):487-93. PubMed ID: 22228231
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants.
Phua KB; Quak SH; Lee BW; Emmanuel SC; Goh P; Han HH; De Vos B; Bock HL
J Infect Dis; 2005 Sep; 192 Suppl 1():S6-S16. PubMed ID: 16088807
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of rhesus rotavirus vaccine MMU-18006 against gastroenteritis due to serotype 1 rotavirus.
Ukae S; Nakata S; Adachi N; Kogawa K; Chiba S
Vaccine; 1994 Aug; 12(10):933-9. PubMed ID: 7975835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
